The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents.
 
Yasser Ged
No Relationships to Disclose
 
Chung-Han Lee
Consulting or Advisory Role - Eisai; Eisai; Exelixis; Exelixis; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai
 
Alejandro Sanchez
No Relationships to Disclose
 
Cihan Duzgol
No Relationships to Disclose
 
Joshua Chaim
No Relationships to Disclose
 
Maria Isabel Carlo
Consulting or Advisory Role - Pfizer
 
Ashley Foster
No Relationships to Disclose
 
Oguz Akin
Consulting or Advisory Role - Ezra AI
 
Darren R. Feldman
Research Funding - Decibel Therapeutics (Inst); Novartis; Seagen
Other Relationship - UpToDate
 
A. Ari Hakimi
No Relationships to Disclose
 
Sujata Patil
No Relationships to Disclose
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Novartis (Inst); Pfizer (Inst)
 
Helena Furberg
No Relationships to Disclose
 
Martin Henner Voss
Honoraria - Novartis
Consulting or Advisory Role - Alexion Pharmaceuticals; Calithera Biosciences; Corvus Pharmaceuticals; Eisai; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Genentech/Roche
Travel, Accommodations, Expenses - Eisai; MedImmune; Takeda